Other

Unfunded Commitments

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ1 2026
Last reportedQ1 2026
Metric ID: other_research_and_development_unfunded_commitments

Historical Data

1 periods
 Q1 '26
Value$600.00M

Product Breakdown

View all
SegmentQ1 '26
JNJ‑4804$500.00M
Litifilimab$25.00M
Total$600.00M

Frequently Asked Questions

What is Royalty Pharma's unfunded commitments?
Royalty Pharma (RPRX) reported unfunded commitments of $600.00M in Q1 2026.